Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04018638 · ClinicalTrials.gov registry record · NA

Blood-Flow Restriction Exercise Following a Knee Replacement

A NA study of Knee Osteoarthritis and Knee Injuries, sponsored by Michigan Technological University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04018638: Active NA study of Knee Osteoarthritis and Knee Injuries, sponsored by Michigan Technological University.

NCT04018638 is a NA study of Knee Osteoarthritis and Knee Injuries that is active but no longer recruiting, run by Michigan Technological University. The registered enrollment target is 30 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04018638, a NA study of Knee Osteoarthritis and Knee Injuries, is active but no longer recruiting, sponsored by Michigan Technological University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will determine the safety and efficacy of using blood-flow restriction exercise enhancement (B-FREE) to overcome persistent quadriceps muscle weakness that occurs following a total knee replacement (TKR).

Primary Outcome

quadriceps muscle thickness

Interventions

  • OTHER B-FREE

Study Locations (1)

Michigan

  • Michigan Technological University - Houghton

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-06-25
Est. Completion 2025-12-25
Phase NA

What the registry record for NCT04018638 still lists

NCT04018638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (90% lower).

The record links to 3 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which B-FREE is the first listed.

NCT04018638 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04018638 about?

NCT04018638 is a clinical study titled "Blood-Flow Restriction Exercise Following a Knee Replacement". This study will determine the safety and efficacy of using blood-flow restriction exercise enhancement (B-FREE) to overcome persistent quadriceps muscle weakness that occurs following a total knee replacement (TKR).

What is the current status of trial NCT04018638?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-25. Estimated completion is 2025-12-25.

What conditions does trial NCT04018638 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Injuries, Knee Arthritis.

What interventions are being tested in trial NCT04018638?

The interventions under investigation include: B-FREE (OTHER).

Who is sponsoring clinical trial NCT04018638?

This trial is sponsored by Michigan Technological University, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04018638 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04018638's enrollment target sits among peer trials

30 80th of 101 higher than 15 of 101 other Knee Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04018638, the US trial registry maintained by the National Library of Medicine. NCT04018638 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.